SEQ Newsletter | Rapid Molecular Methods for Pharmaceutical Manufacturing | Featuring MicroSEQ® Identification and Detection Systems | microseq.com

  What's New
Easy to Use, Higher Throughput, Same High Accuracy: Introducing the MicroSEQ® Rapid System
The new MicroSEQ® Rapid Microbial Identification System is the next-generation, high-throughput genotypic system for routine identification of bacteria and fungi within a pharmaceutical manufacturing environment. Powered by the new 3500 Series Genetic Analyzers and the accuracy of gold standard technology, this next-generation system’s time-to-results can help deliver a measurable financial impact through reducing the amount of re-testing and removing the need to outsource identification of hard-to-identify microbial contaminants.

Contact your local Sales Representative today for a complimentary ROI assessment comparing your current system or service to the MicroSEQ® Rapid System.
CHO Residual DNA Assay Validated by Independent Testing Lab
The resDNASEQ CHO System was validated by a biopharmaceutical contract research organization according to ICH Q2 (R1) guidelines for quantitative tests for impurities. The study demonstrates how the system meets specifications for dynamic range, linearity, specificity, repeatability, intermediate precision, accuracy, and limit of quantitation.

Ask our experts about your internal validation.
Residual DNA Assay Portfolio Expanded to Include E. coli, NS0, and Vero
In addition to CHO, the resDNASEQ™ Host Cell Residual DNA System now includes quantitative real-time PCR assays for E. coli, NS0, and Vero cell lines. The integrated system includes sample preparation, TaqMan® assay and master mix, and genomic DNA standard. The resDNASEQ™ assays, which are available as early-access kits, can be used to perform sensitive and accurate quantitation of subpicogram levels of host cell DNA across a broad range of sample types, from in-process samples to final product for lot release. Quantitative results can be obtained in less than 4 hours.

Click here for information on early-access kits.

Are You Using Rapid Molecular Methods and Twitter?
Follow us on Twitter (www.twitter.com/Molecule2Market) to keep up to date on news, trends, promotions, upcoming events, and technical information in the biopharmaceutical manufacturing industry.
  Issue 6 | September 2010
 
SEQ Events

Rapid Molecular Methods
November 4, 2010, San Diego, CA




Bioproduction Webinar Series

Did you miss the Cell Culture Rapid Methods Program: The Value of Rapid Detection webinar in August? Sign up to access the recorded webinar today.




Upcoming Events
Fall 2010

PDA Microbiology
October 25–28, Washington, DC

PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop
December 1–3, Bethesda, MD




For more information about new products, services, or events, contact us today at bp@lifetech.com.

For Europe, contact Frederic.Bar@lifetech.com.





Read past issues of the SEQ newsletter, and sign up today to receive future editions.
Subscribe now

 
Applied Biosystems

Applied Biosystems
850 Lincoln Centre Dr.
Foster City, CA, 94404
USA
www.appliedbiosystems.com
FOR RESEARCH USE ONLY. NOT INTENDED FOR ANY ANIMAL OR HUMAN THERAPEUTIC OR DIAGNOSTIC USE.
© 2010 Life Technologies Corporation. All rights reserved. The trademarks mentioned herein are the property of Life Technologies Corporation or their respective owners.

In compliance with federal regulations, we hereby disclose that this email communication is for commercial purposes.

View the Applied Biosystems privacy policy.